Aimard G, Garde A, Henry E, Sevez J F
Presse Med. 1984 Apr 14;13(16):979-82.
The case-records of 350 outpatients treated with monoamine oxidase inhibitors have been reviewed. All patients presented with depression, obsessions or phobias. About two-thirds benefited from the drugs, particularly after other treatments (including psychotropic drugs, seismotherapy, psychotherapy and internment) had failed. With the moderate doses administered (iproniazide: 50 mg/day; nialamide: 100 mg/day) side-effects were uncommon and mild and no incident was noted in 32 general anaesthesias given for surgical operations. These findings should help in lifting the ban on this category of drugs. Monoamine oxidase inhibitors are effective, useful and sometimes indispensable after failure of other antidepressants.
对350例接受单胺氧化酶抑制剂治疗的门诊患者的病历进行了回顾。所有患者均表现为抑郁、强迫观念或恐惧症。约三分之二的患者从药物治疗中获益,尤其是在其他治疗(包括精神药物、震动疗法、心理治疗和住院治疗)失败之后。使用中等剂量(异烟肼:50毫克/天;尼亚酰胺:100毫克/天)时,副作用不常见且轻微,在32例外科手术全身麻醉中未发现任何意外情况。这些发现应有助于解除对这类药物的禁令。单胺氧化酶抑制剂是有效的、有用的,而且在其他抗抑郁药无效时有时是不可或缺的。